Advertising
From Pink Slips to Silent Sidelining: Inside adland’s layoff and anxiety crisis
Kimberly-Clark to acquire Band-Aid, Neutrogena owner Kenvue for $48.7 billion
The merged entity is expected to generate $32 billion in annual revenue and $7 billion in adjusted EBITDA,
Kimberly-Clark to take over Kenvue
Kimberly-Clark Corporation has announced plans to acquire Kenvue Inc., the maker of popular consumer health brands such as Band-Aid and Neutrogena, in a deal valued at $48.7 billion.
According to media reports, following the completion of the transaction, Kimberly-Clark shareholders will own approximately 54% of the combined company, while Kenvue shareholders will hold the remaining 46%.
In a statement, Kenvue said the combination will create a $32 billion global health and wellness leader by bringing together complementary portfolios of trusted consumer brands.
The transaction is expected to close in the second half of 2026 and will be financed through a combination of cash and debt, supported by committed funding from JPMorgan Chase Bank.
Reuters reported that Kenvue shareholders will receive $3.50 per share plus 0.15 shares of Kimberly-Clark stock for each Kenvue share held. If the deal does not go through, either party may be liable to pay a termination fee of $1.12 billion.
Following the merger, Kimberly-Clark CEO Mike Hsu will serve as the Chairman and CEO of the combined company.
“By uniting our resources, talent, expertise, and geographic reach, we will unlock new opportunities to innovate faster and strengthen our leadership across categories that matter most to consumers through every stage of life,” the company added.
SPOTLIGHT
From purpose-driven work and narrative-rich brand films to AI-enabled ideas and creator-led collaborations, the awards reflect the full spectrum of modern creativity.
Read More“Confusion creates opportunity for agile players,” Sir Martin Sorrell on industry consolidation
Looking ahead to the close of 2025 and into 2026, Sorrell sees technology platforms as the clear winners. He described them as “nation states in their own right”, with market capitalisations that exceed the GDPs of many countries.